» Articles » PMID: 26528887

Interaction of ApoE3 and ApoE4 Isoforms with an ITM2b/BRI2 Mutation Linked to the Alzheimer Disease-like Danish Dementia: Effects on Learning and Memory

Overview
Date 2015 Nov 4
PMID 26528887
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in Amyloid β Precursor Protein (APP) and in genes that regulate APP processing--such as PSEN1/2 and ITM2b/BRI2--cause familial dementia, such Familial Alzheimer disease (FAD), Familial Danish (FDD) and British (FBD) dementias. The ApoE gene is the major genetic risk factor for sporadic AD. Three major variants of ApoE exist in humans (ApoE2, ApoE3, and ApoE4), with the ApoE4 allele being strongly associated with AD. ITM2b/BRI2 is also a candidate regulatory node genes predicted to mediate the common patterns of gene expression shared by healthy ApoE4 carriers and late-onset AD patients not carrying ApoE4. This evidence provides a direct link between ITM2b/BRI2 and ApoE4. To test whether ApoE4 and pathogenic ITM2b/BRI2 interact to modulate learning and memory, we crossed a mouse carrying the ITM2b/BRI2 mutations that causes FDD knocked-in the endogenous mouse Itm2b/Bri2 gene (FDDKI mice) with human ApoE3 and ApoE4 targeted replacement mice. The resultant ApoE3, FDDKI/ApoE3, ApoE4, FDDKI/ApoE4 male mice were assessed longitudinally for learning and memory at 4, 6, 12, and 16-17 months of age. The results showed that ApoE4-carrying mice displayed spatial working/short-term memory deficits relative to ApoE3-carrying mice starting in early middle age, while long-term spatial memory of ApoE4 mice was not adversely affected even at 16-17 months, and that the FDD mutation impaired working/short-term spatial memory in ApoE3-carrying mice and produced impaired long-term spatial memory in ApoE4-carrying mice in middle age. The present results suggest that the FDD mutation may differentially affect learning and memory in ApoE4 carriers and non-carriers.

Citing Articles

From Noise to Knowledge: Diffusion Probabilistic Model-Based Neural Inference of Gene Regulatory Networks.

Zhu H, Slonim D J Comput Biol. 2024; 31(11):1087-1103.

PMID: 39387266 PMC: 11698671. DOI: 10.1089/cmb.2024.0607.


Prophylactic effect of chronic immunosuppression in a mouse model of CSF-1 receptor-related leukoencephalopathy.

Chitu V, Biundo F, Oppong-Asare J, Gokhan S, Aguilan J, Dulski J Glia. 2023; 71(11):2664-2678.

PMID: 37519044 PMC: 10529087. DOI: 10.1002/glia.24446.


BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides.

Zhou J, Singh N, Galske J, Hudobenko J, Hu X, Yan R Mol Neurodegener. 2023; 18(1):31.

PMID: 37143090 PMC: 10161466. DOI: 10.1186/s13024-023-00611-w.


Elevated granulocyte colony stimulating factor (CSF) causes cerebellar deficits and anxiety in a model of CSF-1 receptor related leukodystrophy.

Biundo F, Chitu V, Tindi J, Burghardt N, Shlager G, Ketchum H Glia. 2022; 71(3):775-794.

PMID: 36433736 PMC: 9868112. DOI: 10.1002/glia.24310.


Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function.

Orr A, Kim C, Jimenez-Morales D, Newton B, Johnson J, Krogan N J Alzheimers Dis. 2019; 68(3):991-1011.

PMID: 30883359 PMC: 6481541. DOI: 10.3233/JAD-181184.


References
1.
Suh Y, Kim H, Lee J, Park C, Jeong S, Rah J . Roles of A beta and carboxyl terminal peptide fragments of amyloid precursor protein in Alzheimer disease. J Neural Transm Suppl. 2000; (58):65-82. DOI: 10.1007/978-3-7091-6284-2_6. View

2.
West H, Rebeck G, Hyman B . Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett. 1994; 175(1-2):46-8. DOI: 10.1016/0304-3940(94)91074-x. View

3.
Vidal R, Revesz T, Rostagno A, Kim E, Holton J, Bek T . A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci U S A. 2000; 97(9):4920-5. PMC: 18333. DOI: 10.1073/pnas.080076097. View

4.
Selkoe D . Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J Clin Invest. 2002; 110(10):1375-81. PMC: 151820. DOI: 10.1172/JCI16783. View

5.
Flory J, Manuck S, Ferrell R, Ryan C, Muldoon M . Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am J Med Genet. 2000; 96(6):707-11. DOI: 10.1002/1096-8628(20001204)96:6<707::aid-ajmg1>3.0.co;2-v. View